Michael C LeCompte
Overview
Explore the profile of Michael C LeCompte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
LeCompte M, Vuppala N, Reyes J, Page B, Croog V, Huang E, et al.
Neurooncol Adv
. 2025 Feb;
7(1):vdaf004.
PMID: 39991181
Background: The optimal regimen, normal tissue tolerances, and appropriate indications for reirradiation for recurrent high-grade glioma (HGG) are uncertain. The aim of this study was to determine whether higher reirradiation...
2.
LeCompte M, Gibbs I, Taparra K, Suneja G, Deville Jr C, White 2nd Z, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jun;
120(4):940-945.
PMID: 38944312
No abstract available.
3.
Khullar K, Deek R, Nelson B, Gaines D, Corrigan K, LeCompte M, et al.
Adv Radiat Oncol
. 2024 Jan;
9(1):101305.
PMID: 38260226
Purpose: We hypothesized that there may be a gender disparity in the receipt of the Association of Residents in Radiation Oncology (ARRO) Educator of the Year Award and sought to...
4.
Patel P, Cao Y, Chen X, LeCompte M, Kleinberg L, Khan M, et al.
Adv Radiat Oncol
. 2024 Jan;
9(1):101327.
PMID: 38260225
Purpose: Although surgical decompression is the gold standard for metastatic epidural spinal cord compression (MESCC) from solid tumors, not all patients are candidates or undergo successful surgical Bilsky downgrading. We...
5.
LeCompte M, Vidal G, Rivera A, Sim A, Chaurasia A, Pereira I, et al.
Int J Radiat Oncol Biol Phys
. 2023 May;
116(2):328-333.
PMID: 37179090
No abstract available.
6.
Lee E, Chen X, LeCompte M, Kleinberg L, Hales R, Voong K, et al.
J Neurosurg Spine
. 2023 May;
39(2):278-286.
PMID: 37148233
Objective: Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized the treatment of patients with many tumor histologies. Simultaneously, stereotactic body radiotherapy (SBRT) provides excellent local control (LC) and plays an...
7.
Shaaban S, LeCompte M, Kleinberg L, Redmond K, Page B
Curr Treat Options Oncol
. 2023 May;
24(7):880-891.
PMID: 37145381
Cranial radiation is ubiquitous in the treatment of primary malignant and benign brain tumors as well as brain metastases. Improvement in radiotherapy targeting and delivery has led to prolongation of...
8.
LeCompte M, Brawley O
JACC CardioOncol
. 2023 Mar;
5(1):67-69.
PMID: 36875901
No abstract available.
9.
Chen X, LeCompte M, Gui C, Huang E, Khan M, Hu C, et al.
Radiother Oncol
. 2022 Jun;
173:215-222.
PMID: 35667571
Background And Purpose: To analyze the impact of target delineation on local control (LC) after stereotactic body radiotherapy (SBRT) for spine metastasis. Materials And Methods: Patients with de novo metastasis...
10.
Farris M, Helis C, Hughes R, LeCompte M, Borg A, Nieto K, et al.
Cancers (Basel)
. 2020 Feb;
12(2).
PMID: 32059447
Ionizing radiation is a critical aspect of current cancer therapy. While classically mature bone was thought to be relatively radio-resistant, more recent data have shown this to not be the...